CACLP - The largest IVD Expo & Conference

BD Receives FDA 510(k) Clearance for Advanced Microbiology Solution

Industry news | 14 April, 2025 | CACLP

Original from: BD (Becton, Dickinson and Company) 

 

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for BD Phoenix™ M50 and BDXpert™ System on the BD Synapsys™ Informatics Solution, leveraging rapid identification (ID) and antimicrobial susceptibility testing (AST) algorithms to assist in the interpretation of complex diagnostic data to help ensure accurate and reliable diagnoses related to antimicrobial resistance (AMR).

 

BDXpert™ is an automated, rule-based system that analyzes ID and AST results from the BD Phoenix™ M50 Automated Microbiology System, further enhancing its capabilities. By integrating with the BD Synapsys™ Informatics Solution, this system aids laboratorians in addressing ongoing challenges related to understaffing, increased testing demands and evolving susceptibility testing standards by helping streamline data management, helping reduce the potential for errors, and providing the delivery of critical test results and accurate information to clinicians.

 

"Bacterial AMR contributes to nearly five million deaths each year around the world,” said Nikos Pavlidis, worldwide president, BD Diagnostic Solutions. “Rapid and precise ID/AST results lead to timely and appropriate treatment, helping reduce the spread of resistant infections and ensuring the right medication is used to combat the infection.”

 

The BDXpert™ system, when integrated with the cutting-edge technology of BD Synapsys™ and the BD Phoenix™ M50 automated system, offers a significant advancement in diagnostic microbiology, helping provide accuracy and efficiency to support clinical microbiology laboratories.

 

The integrated BDXpert™ system on BD Synapsys™ will be showcased at the upcoming European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress from April 11-15, in Vienna, Austria, booth C55.

 

Source: BD Receives FDA 510(k) Clearance for Advanced Microbiology Solution

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 1808, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference